Literature DB >> 14561688

Endogenous zinc inhibits GABA(A) receptors in a hippocampal pathway.

Arnaud Ruiz1, Matthew C Walker, Ruth Fabian-Fine, Dimitri M Kullmann.   

Abstract

Depending on their subunit composition, GABA(A) receptors can be highly sensitive to Zn(2+). Although a pathological role for Zn(2+)-mediated inhibition of GABA(A) receptors has been postulated, no direct evidence exists that endogenous Zn(2+) can modulate GABAergic signaling in the brain. A possible explanation is that Zn(2+) is mainly localized to a subset of glutamatergic synapses. Hippocampal mossy fibers are unusual in that they are glutamatergic but have also been reported to contain GABA and Zn(2+). Here, we show, using combined Timm's method and post-embedding immunogold, that the same mossy fiber varicosities can contain both GABA and Zn(2+). Chelating Zn(2+) with either calcium-saturated EDTA or N,N,N',N'-tetrakis (2-pyridylmethyl)ethylenediamine had no effect on stratum-radiatum-evoked inhibitory postsynaptic currents (IPSCs), but enhanced IPSCs evoked by stimuli designed to recruit dentate granule cells. We also show that IPSCs recorded in CA3 pyramidal neurons in acute hippocampal slices are depressed by exogenous Zn(2+). This depression was of similar amplitude whether the IPSCs were evoked by stimulation in s. radiatum (to recruit local interneurons) or in the s. granulosum of the dentate gyrus (to recruit mossy fibers). These results show for the first time that GABAergic IPSCs can be modulated by endogenous Zn(2+) and are consistent with GABA release at Zn(2+)-containing mossy fiber synapses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14561688     DOI: 10.1152/jn.00755.2003

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  40 in total

1.  Differential Effects of Low- and High-dose Zinc Supplementation on Synaptic Plasticity and Neurogenesis in the Hippocampus of Control and High-fat Diet-fed Mice.

Authors:  Sung Min Nam; Jong Whi Kim; Hyun Jung Kwon; Dae Young Yoo; Hyo Young Jung; Dae Won Kim; In Koo Hwang; Je Kyung Seong; Yeo Sung Yoon
Journal:  Neurochem Res       Date:  2017-08-02       Impact factor: 3.996

2.  Selective block of the human 2-P domain potassium channel, TASK-3, and the native leak potassium current, IKSO, by zinc.

Authors:  Catherine E Clarke; Emma L Veale; Paula J Green; Helen J Meadows; Alistair Mathie
Journal:  J Physiol       Date:  2004-07-29       Impact factor: 5.182

Review 3.  The neurophysiology and pathology of brain zinc.

Authors:  Stefano L Sensi; Pierre Paoletti; Jae-Young Koh; Elias Aizenman; Ashley I Bush; Michal Hershfinkel
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

4.  Zinc inhibition of gamma-aminobutyric acid transporter 4 (GAT4) reveals a link between excitatory and inhibitory neurotransmission.

Authors:  Einav Cohen-Kfir; William Lee; Sepehr Eskandari; Nathan Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-13       Impact factor: 11.205

5.  pH-dependent inhibition of kainate receptors by zinc.

Authors:  David D Mott; Morris Benveniste; Raymond J Dingledine
Journal:  J Neurosci       Date:  2008-02-13       Impact factor: 6.167

Review 6.  Is zinc a neuromodulator?

Authors:  Alan R Kay; Katalin Tóth
Journal:  Sci Signal       Date:  2008-05-13       Impact factor: 8.192

7.  Zinc transporter ZnT-3 regulates presynaptic Erk1/2 signaling and hippocampus-dependent memory.

Authors:  Carlos Sindreu; Richard D Palmiter; Daniel R Storm
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-18       Impact factor: 11.205

8.  Modulation of extrasynaptic NMDA receptors by synaptic and tonic zinc.

Authors:  Charles T Anderson; Robert J Radford; Melissa L Zastrow; Daniel Y Zhang; Ulf-Peter Apfel; Stephen J Lippard; Thanos Tzounopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-06       Impact factor: 11.205

9.  Endogenous zinc in neurological diseases.

Authors:  Jae-Yong Koh
Journal:  J Clin Neurol       Date:  2005-10-20       Impact factor: 3.077

10.  ZnT3 mRNA levels are reduced in Alzheimer's disease post-mortem brain.

Authors:  Nancy Beyer; David Tr Coulson; Shirley Heggarty; Rivka Ravid; G Brent Irvine; Jan Hellemans; Janet A Johnston
Journal:  Mol Neurodegener       Date:  2009-12-23       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.